Risperdal Settlement Amounts

Recent Risperdal Settlements

The makers of Risperdal have settled with the Department of Justice in 2013 for over 2.2 Billion Dollars. Currently they are settling with the States, and the Risperdal Settlement amounts are staggering. There is no doubt that people that were affected by the drug Risperdal will be next in line for a Risperdal Settlement. The Big question is what will the Risperdal Settlement amounts be.

Risperdal Belwether trials have yielded verdicts for the victims of 2.5 million, 1.75 million, and 500,000 thousand dollars. These trials help create a matrix for the Risperdal Settlement. What will happen next is that after intense negotiations between the attorneys on the Plaintiff Steering Committee,  and the attorneys for Johnson and Johnson, a Settlement will be reached.

Expect the Risperdal Settlement to have a graduated curve to it. For example an adolescent who developed gynoclamastia, and had breast reduction surgery will receive more then an adult who has gynoclamastia but did not have surgery.

We have heard from some members of the Plaintiff Steering Committee and the Risperdal Settlement amounts are much larger then they originally anticipated.

We have been told and mind you this is complete conjecture until the Risperdal Settlement is announced that people  specifically adolescents that had breast reduction surgery could see settlements between $800,000-1.2 million dollars.

The key here is that they had breast reduction surgery, many have had liposuction, and the younger you were when the surgery occurred the higher your award.

Possible Risperdal Settlement Amounts

We have also heard that people, specifically adults that suffered from gynoclamastia but have not had surgery would see between $100,000 to $200,000 dollars. Again keep in mind these numbers are pure conjecture at this point, but in speaking with different members of the Plaintiff Steering Committee there does seem to be a consensus.

In our estimation we will see a Risperdal Settlement in the very near future.

If you or a loved one took the drug Risperdal, please call us at 1-888-366-9595.

Risperdal Settlement Amounts

Risperdal Settlement Amounts Revised

Recent developments in the Risperdal Settlement include a $2.5 million dollar verdict out of Philadelphia, this occurred on 2/25/15.

This has spawned an onslaught of attorney advertising, and possibly expanded the scope of the Risperdal Settlement

The potential Risperdal Settlement amounts may have increased almost two fold.

It also seems as though men who took Risperdal will also be covered, not just males under the age of 18.

Risperdal causes gynecomastia, which is the enlargement of the male breast, at this point in time the Risperdal settlement is only for males.

It is thought by certain members of the Risperdal P.S.C which controls the Risperdal Settlement for those affected by Risperdal. That the bellwether trials yet to come will be more bad news for Johnson and Johnson.

Johnson and Johnson have already had to pay 2.2 Billion dollars to the Department of Justice as the J&J Subsidiary Janssen Pleaded Guilty to Misbranding the Antipsychotic Drug.

As I was writing this I just spoke to a distinguished member of the Plaintiffs Steering Committee that told me they have over 30 million documents that establish a string of deception by Jansen and Johnson and Johnson.

Johnson and Johnson have a history of coming to quick settlements if it can be found that they were grossly negligent. We believe that there is a very good chance that will be the case here.

Mind you, nobody knows for sure what Risperdal Settlements amounts will be, but with the new developments, this is looking more like the breakdown.

Revised Risperdal Settlement Amounts.

$100,000-$200,000it is expected for a man who suffers from gynecomastia.

$400,000-$600,000 if you had revision surgery such as liposuction.

Call Us for More information 1-888-366-9595

The Risperdal Scandal: Off-label Marketing

The Risperdal lawsuit is ongoing, and complicated.

In this article we will discuss the different charges Janssen Pharmaceuticals, the maker of Risperdal, is facing regarding illegal marketing practices with their drug Risperdal.

Janssen is putting profits over safety, putting lives at risk.

Janssen Pharmaceuticals is a subsidiary of Johnson and Johnson.

Risperdal has a long, dark history of bribery, illegal marketing, and dangerous side effects.

Risperdal is a brand name, atypical antipsychotic medication. It’s active ingredient is called risperdone.

Janssen now faces many Risperdal lawsuits, and has already plead guilty to advertising the drug for “off-label” uses.

Off-label marketing is when a company advertises for a drug to be used for purposes that are not FDA approved; they are “off the label” uses.

What are the FDA Approved Uses of Risperdal?

Originally, Risperdal was released in 1993.

At first Risperdal was only FDA approved for treating psychosis in adults with schizophrenia. Risperdal was later FDA approved for children aged 5-17 to help with the irritability associated with autism spectrum disorders.

On August 22nd, 2007, Risperdal received FDA approval to be used for treating schizophrenia in adolescents aged 13-17, and short term treatment of mania, a symptom of bipolar disorder in kids age 10 and up.

Risperdal became the first atypical antipsychotic drug to be approved to treat schizophrenia and bipolar disorder in children.

However, doctors are urged to keep in mind that Risperdal has serious side effects such as weight gain, and can cause gynecomastia in adolescent boys.

Johnson and Johnson has been sued for marketing Risperdal illegally for use with children with ADHD, persons with intellectual disability, and older adults with dementia.

Prosecutors accuse Johnson and Johnson of targeting our most vulnerable populations with what is essentially a chemical restraint.

Janssen Pharmaceuticals is also accused of down playing the risks of Risperdal, while marketing the drug for unapproved uses. This is not the first time Janssen Pharmaceuticals has gotten into trouble over Risperdal.

 Janssen Has a History of Illegally Marketing Risperdal

The current Risperdal scandal is certainly not the first: Janssen has been sued by numerous state governments for their unethical and illegal marketing of Risperdal.

Risperdal was sold illegally as a “chemical restraint” in nursing homes, putting lives at risk.

Risperdal is not approved for use with dementia in the elderly, but it has been used for such in the past.

Risperdal becomes what is known as a “chemical restraint” in a nursing home setting, ensuring that elderly residents will sleep through the night. Charges brought forth against Janssen allege that the company pitched sales to nursing homes saying they would save money by need less staff thanks to the sedative effect of Risperdal.

Former employees of Janssen Pharmaceuticals began to step forward.

They were called whistle blowers. They came forward and testified against Janssen in state court.

Former Janssen Employees Testify in Risperdal Lawsuit

Whistle blower Judy Doetterl testified that she was pressured to sell Risperdal to elder care facilities, saying that 70% of her bonus depended on it.

Doetterl knew that Risperdal was not FDA approved for use with dementia, and complained to management. Her complaints were ignored.

Doetterl wasn’t the only whistle bower to come forward; 7 others testified against Janssen for their illegal marketing of Risperdal.

Kurtis Barry, another whistle blower in the Risperdal lawsuit, was a former regional sales manager for Janssen Pharmaceuticals. He testified that the CEO of Johnson and Johnson, Alex Gorsky, knowingly and willingly directed that Risperdal be marketed to the elderly for use with dementia.

“The decision to market, promote and sell Risperdal for off-label purposes to the elderly population was made affirmatively and deliberately by defendants’ executive and management personnel, and carried out under their authority and direction.” – Kurtis Barry

The problem is, Risperdal can be deadly for the elderly. The FDA has issued a blackbox warning on Risperdal packaging warning about the risks of taking Risperdal as an older adult.

The FDA Black Box Warning on Risperdal Labels.

When given to older adults with dementia, Risperdal increases the likelihood of death from conditions such as pneumonia and stroke.

Risperdal is not, nor has it ever been approved for use with older adults with dementia.

Janssen Pays Risperdal Settlements

Janssen has lost over and over again in state courts across the nation, yet is careful not to own up to their actions, saying they agree with the principles the prosecutors are standing by, but do not feel as though they violated the law.

Janssen officials say they agree with the sentiment that medicine should only be used for FDA approved purposes, but they deny having participated in any wrong-doing regarding the marketing of Risperdal to children.

Janssen was also found to have been giving illegal and unethical incentives to doctors and hospitals to prescribe Risperdal.

Even though they deny wrong-doing in public statements, Janssen continues to plead guilty in the court room, paying billions in settlements.

The Risperdal scandal has resulted in the 3rd largest medical settlement in history.

Johnson and Johnson has been fined over $2.2 billion dollars for the inappropriate and illegal marketing of Risperdal.

The Risperdal lawsuit alleged that Janssen Pharmaceuticals illegally marketed Risperdal the the elderly and children with certain behavioral disorders.

Given that Risperdal isn’t approved for these uses, the prosecutor claimed Janssen Pharmaceuticals put some of our most vulnerable populations – children and the elderly – at risk, because Risperdal has serious side effects and can be deadly to the elderly.

Despite the large Risperdal settlement amounts being awarded on state and federal levels, Johnson and Johnson continues to profit on sales of Risperdal.

The Risperdal Gynecomastia Lawsuit

Can Janssen continue to rake in enough sales to break the law?

Janssen has been court-ordered to pay billions in Risperdal settlements, but Risperdal is still a profitable drug for Johnson and Johnson.

This is why many feel as though a lawsuit is the only way they can fight back after being manipulated and injured by a corporation like Johnson and Johnson.

We help the “little guy” fight back.

If you have been affected by Risperdal gynecomastia you have experienced pain and suffering, weight gain, hormonal imbalance, and you may have needed corrective surgery for the gynecomastia.

If you have experienced these Risperdal side effects we strongly urge you to seek legal advice, as recovering from Risperdal gynecomastia can be an expensive and painful journey.

Attorneys Band Gates & Dramis offers free, no obligation Risperdal claims evaluations.

Plaintiffs in the current Risperdal lawsuit feel as though Janssen is liable for any damages, due to the aggressive nature in which Risperdal was marketed and the fact that Janssen chose not to warn users about the possible side effect of hormonal imbalance and gynecomastia.

To begin researching your claim with Risperdal lawyers today, fill out the online form on this page or simply call the number below.

We do not charge a fee unless you collect a settlement.

Risperdal Lawsuit Help

1-888-366-9595

Risperdal Lawsuit News: Settlements Won

Settlements Reached Quickly in Early Risperdal Gynecomastia Lawsuits

The Risperdal lawsuit is in full swing, having already settled several claims. The first Risperdal lawsuit was filed on behalf of a young man who developed male breasts after taking Risperdal. It was settled on the first day of court, in September, 2012.

Five more Risperdal settlements were negotiated in state courts of Pennsylvania on October 3, 2012.

The plaintiffs alleged that Risperdal, an atypical antipsychotic medication caused them to develop male breasts, a condition known as gynecomastia.

They claim that Janssen, the pharmaceutical subsidiary of Johnson and Johnson failed to warn them about their risks of developing gynecomastia.

Plaintiffs in the Risperdal lawsuit also allege the drug was marketed for unapproved, or “off label” uses.

Janssen is being held responsible for their medical bills and pain and suffering, but the settlement amounts for the Risperdal lawsuits were not disclosed publicly.

There is speculation that the Janssen’s defense is settling before the testimony of Dr. David Kessler, a former FDA commissioner, is put on record.

Dr. Kessler has stated publicly that he believes Janssen broke the law by marketing Risperdal for unapproved, off label uses.

State Courts are Suing Johnson and Johnson for Improper Marketing

Johnson and Johnson has already been ordered to pay out hundreds of millions of dollars in Risperdal settlements to state courts.

For example Louisiana has ordered Johnson and Johnson to pay $258 million in penalties for making false claims about the safety of Risperdal.

When a manufacturer sells a drug they can only advertise it for FDA approved uses. In the case of Risperdal, claimants allege that the drug was improperly marketed for unapproved uses to both children and the elderly.

Risperdal has been found to increase mortality rates in the elderly, causing a higher risk of death due to conditions such as pneumonia and heart attack.

South Carolina courts have ordered a $327 million dollar penalty against the company for illegal marketing.

In addition to off label marketing, Johnson and Johnson is accused of giving doctors financial incentives to prescribe Risperdal.

Many other states have expressed interest in suing Johnson and Johnson for medicare reimbursement, on the basis that the company marketed it for off label uses.

 It’s the Right Time to Start Your Risperdal Lawsuit

If you have been affected by Risperdal gynecomastia, you may be eligible for compensation from a Risperdal lawsuit. The Risperdal lawsuit is currently being organized into an MDL, and over 600 individual claims are pending.

Click here to learn about the pending Risperdal MDL.

Once the Risperdal MDL is formed, a Risperdal settlement is expected to be awarded shortly after. Now is the time to find out if you qualify for a Risperdal settlement.

Fill out the online claim form on this page, or call the number below for a free consultation.

Risperdal Lawsuit Help

1-888-366-9595